# Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer

> **NCT00004175** · PHASE2 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** docetaxel
- **DRUG:** doxorubicin hydrochloride
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00004175
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** 2004-09
- **Final completion:** 2005-06
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004175, "Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*